Business Context and Reporting Period
Company: Humana Inc.
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2003
Business Overview: Humana is a major publicly traded health benefits company offering coordinated health insurance coverage through traditional and Internet-based plans. The company operates two primary segments: Commercial (employer groups and individuals) and Government (Medicare+Choice, Medicaid, and TRICARE). As of December 31, 2003, Humana served approximately 6.8 million medical members and 1.7 million specialty product members. Approximately 42% of premiums and administrative services fees were derived from federal government contracts.
Key Financial Metrics
| Metric | 2003 | 2002 |
|---|---|---|
| Total Revenues | $12,226 million | $11,261 million |
| Net Income | $229 million | $143 million |
| Diluted EPS | $1.41 | $0.85 |
| Medical Expense Ratio | 83.5% | 83.6% |
| SG&A Expense Ratio | 15.4% | 15.9% |
| Cash and Cash Equivalents | $931 million | $721 million |
| Total Debt | $643 million | $605 million |
| Stockholders' Equity | $1,836 million | $1,606 million |
Cash Flow: Net cash provided by operating activities was $413 million in 2003. The company repurchased 3.7 million shares of common stock for $44 million and invested $101 million in capital expenditures.
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased 8.6% to $12.2 billion, driven primarily by a 12.4% increase in Commercial segment premiums and a 12.4% increase in TRICARE premiums.
- Profitability Surge: Net income increased 60% to $229 million. The Commercial segment turned a loss of $15 million in 2002 into a profit of $121 million in 2003, largely due to improved underwriting margins and reduced administrative costs.
- Expense Management: The Medical Expense Ratio improved slightly to 83.5%. The SG&A expense ratio decreased to 15.4%, aided by the absence of $30 million in 2002 expenses related to a contingent contractual provider dispute and reduced severance costs ($11 million in 2003 vs. $40 million in 2002).
- Membership Trends: Total medical membership grew 1.8% to 6.77 million. Commercial fully insured membership grew 0.5%, while Government TRICARE membership grew 5.3%. Medicare+Choice membership declined 4.5% due to market exits and attrition.
Guidance, Outlook, and Risks
Outlook and Strategy:
- Commercial Segment: Management expects 2004 fully insured per member premiums to increase 8-10%, with membership growth of 6-9% (driven by ASO business). The Medical Expense Ratio is expected to increase 100-130 basis points due to competitive pricing pressures.
- Government Segment: The company anticipates growth in MedicareAdvantage membership to 340,000-360,000 by end of 2004, with per member premium increases of 8-10% following the Medicare Prescription Drug, Improvement, and Modernization Act (DIMA).
- TRICARE Transition: A major contract restructuring is underway. TRICARE membership is expected to temporarily decline to 1.5 million in July 2004 before rising to 2.8 million in November 2004 as the company transitions to the new "South Region" contract.
Risks and Contingencies:
- Legal Proceedings: Humana is a defendant in In re Managed Care Litigation, a class action alleging improper claim payments and "downcoding." A trial date is set for September 2004. The company also settled an antitrust suit in Ohio/Kentucky, agreeing to increase physician reimbursements by $45 million over three years.
- Regulatory Environment: Significant exposure to federal and state regulations, including the implementation of HIPAA and DIMA. Changes in government reimbursement rates or benefit mandates could materially impact results.
- Medical Cost Trends: Profitability is sensitive to medical cost inflation and the accuracy of Incurred But Not Reported (IBNR) estimates. A 1% change in the IBNR estimate could impact liabilities by approximately $13 million.
Investor Verification Checklist
- TRICARE Transition Impact: Verify the actual membership and revenue impact of the July-November 2004 TRICARE contract transition, as temporary declines are expected.
- Commercial Margin Sustainability: Monitor the Commercial segment's Medical Expense Ratio in 2004, as management forecasts an increase due to competitive pricing and benefit reductions.
- Legal Exposure: Track the status of the In re Managed Care Litigation class action trial and potential settlement outcomes.
- IBNR Reserves: Review quarterly updates on Incurred But Not Reported (IBNR) medical expense reserves, as these estimates are critical to reported profitability.
- Ochsner Acquisition: Confirm the closing of the pending acquisition of Ochsner Health Plan (expected Q2 2004) and its integration into the Commercial segment.